110 related articles for article (PubMed ID: 33509206)
1. High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon.
Rodrigues EPS; Abreu IN; Lima CNC; da Fonseca DLM; Pereira SFG; Dos Reis LC; Vallinoto IMVC; Guerreiro JF; Vallinoto ACR
Int J Equity Health; 2021 Jan; 20(1):50. PubMed ID: 33509206
[TBL] [Abstract][Full Text] [Related]
2. Anti-SARS-CoV-2 antibodies among indigenous populations of the Brazilian Amazon: a cross-sectional study.
Lima CNC; Abreu IN; Rodrigues EPS; Freitas VO; Botelho BJS; Souza SL; Cayres-Vallinoto I; Guerreiro JF; Ishak R; Vallinoto ACR
BMJ Open; 2022 Feb; 12(2):e054271. PubMed ID: 35131827
[TBL] [Abstract][Full Text] [Related]
3. Migration in times of pandemic: SARS-CoV-2 infection among the Warao indigenous refugees in Belém, Pará, Amazonia, Brazil.
da Silva HP; Abreu IN; Lima CNC; de Lima ACR; do Nascimento Barbosa A; de Oliveira LR; Fujishima MA; Lima SS; de Lima VN; Castelo-Branco S; Vallinoto ACR
BMC Public Health; 2021 Sep; 21(1):1659. PubMed ID: 34511064
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population.
Bichara CDA; da Silva Graça Amoras E; Vaz GL; da Silva Torres MK; Queiroz MAF; do Amaral IPC; Vallinoto IMVC; Bichara CNC; Vallinoto ACR
BMC Infect Dis; 2021 May; 21(1):443. PubMed ID: 33992073
[TBL] [Abstract][Full Text] [Related]
5. Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.
Pontes GS; de Melo Silva J; Pinheiro-Silva R; Barbosa AN; Santos LC; de Pádua Quirino Ramalho A; de Castro Alves CE; da Silva DF; de Oliveira LC; da Costa AG; Bruno AC
Sci Rep; 2021 Sep; 11(1):17534. PubMed ID: 34475438
[TBL] [Abstract][Full Text] [Related]
6. Host genetics and the profile of COVID-19 in indigenous people from the Brazilian Amazon: A pilot study with variants of the ACE1, ACE2 and TMPRSS2 genes.
Putira Sacuena ER; Lima CNC; Abreu IN; da Silva LMC; Belleza LKG; Lemes RB; de Araújo GS; da Silva HP; Vallinoto ACR; Guerreiro JF
Infect Genet Evol; 2024 Mar; 118():105564. PubMed ID: 38307396
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of human T-lymphotropic virus 2 (HTLV-2) infection in villages of the Xikrin tribe (Kayapo), Brazilian Amazon region.
Braço ILJ; de Sá KSG; Waqasi M; Queiroz MAF; da Silva ANR; Cayres-Vallinoto IMV; Lima SS; de Oliveira Guimarães Ishak M; Ishak R; Guerreiro JF; Vallinoto ACR
BMC Infect Dis; 2019 May; 19(1):459. PubMed ID: 31117977
[TBL] [Abstract][Full Text] [Related]
8. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in the Indigenous Population of Brazil.
Palamim CVC; Ortega MM; Marson FAL
J Racial Ethn Health Disparities; 2020 Dec; 7(6):1053-1058. PubMed ID: 33025421
[TBL] [Abstract][Full Text] [Related]
10. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
13. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
[TBL] [Abstract][Full Text] [Related]
14. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
[TBL] [Abstract][Full Text] [Related]
15. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
[TBL] [Abstract][Full Text] [Related]
16. Testing for COVID-19: a few points to remember.
Krátká Z; Luxová Š; Malíčková K; Fürst T; Šimková H
Cas Lek Cesk; 2020; 159(2):72-77. PubMed ID: 32434339
[TBL] [Abstract][Full Text] [Related]
17. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Rodrigues Bomfim R; Grespan R; Santana Rodrigues L; Dos Santos DM; de Sá Resende A; de Lima Silva N; da Silva Santos ACR; Dantas Araújo JM; de Souza MF; de Oliveira Góes MA; Santana Santos V; Martins-Filho PR
Epidemiol Infect; 2021 May; 149():e130. PubMed ID: 34001292
[TBL] [Abstract][Full Text] [Related]
19. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.
Qian C; Zhou M; Cheng F; Lin X; Gong Y; Xie X; Li P; Li Z; Zhang P; Liu Z; Hu F; Wang Y; Li Q; Zhu Y; Duan G; Xing Y; Song H; Xu W; Liu BF; Xia F
Clin Chem Lab Med; 2020 Aug; 58(9):1601-1607. PubMed ID: 32609640
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia.
Megasari NLA; Utsumi T; Yamani LN; Juniastuti ; Gunawan E; Furukawa K; Nishimura M; Lusida MI; Mori Y
PLoS One; 2021; 16(5):e0251234. PubMed ID: 33956869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
